Literature DB >> 20211980

Female mice target deleted for the neuromedin B receptor have partial resistance to diet-induced obesity.

Gabriela Silva Monteiro Paula1, Luana Lopes Souza, Adriana Cabanelas, Flavia Fonseca Bloise, Valéria Mello-Coelho, Etsuko Wada, Tania Maria Ortiga-Carvalho, Karen Jesus Oliveira, Carmen Cabanelas Pazos-Moura.   

Abstract

Previous studies have proposed a role for neuromedin B (NB), a bombesin-like peptide, in the control of body weight homeostasis. However, the nature of this role is unclear. The actions of NB are mediated preferentially by NB-preferring receptors (NBRs). Here we examined the consequences of targeted deletion of NBRs in female mice on body weight homeostasis in mice fed a normolipid diet (ND) or a high-fat diet (HFD) for 13 weeks. Body weight and food ingestion of neuromedin B receptor knockout (NBR-KO) mice fed a normolipid diet showed no difference in relation to wild-type (WT). However, the high-fat diet induced an 8.9- and 4.8-fold increase in body weight of WT and NBR-KO, respectively, compared to their controls maintained with a normolipid diet, even though the mice ingested the same amount of calories, regardless of genotype. Comparing mice fed the high-fat diet, NBR-KO mice accumulated approximately 45% less fat depot mass than WT, exhibited a lower percentage of fat in their carcasses (19.2 vs. 31.3%), and their adipocytes were less hypertrophied. Serum leptin and leptin mRNA in inguinal and perigonadal fat were lower in HFD NBR-KO than HFD WT, and serum adiponectin was similar among HFD groups and unaltered in comparison to ND-fed mice. HFD-fed WT mice developed glucose intolerance but not the HFD-fed NBR-KO mice, although they had similar glycaemia and insulinaemia. NBR-KO and WT mice on the normolipid diet showed no differences in any parameters, except for a trend to lower insulin levels. Therefore, disruption of the neuromedin B receptor pathway did not change body weight homeostasis in female mice fed a normolipid diet; however, it did result in partial resistance to diet-induced obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211980      PMCID: PMC2876815          DOI: 10.1113/jphysiol.2009.185322

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  Intramuscular lipid content is increased in obesity and decreased by weight loss.

Authors:  B H Goodpaster; R Theriault; S C Watkins; D E Kelley
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

2.  Effect of thyroid hormones on pituitary neuromedin B and possible interaction between thyroid hormones and neuromedin B on thyrotropin secretion.

Authors:  T M Ortiga-Carvalho; J Polak; S McCann; C C Pazos-Moura
Journal:  Regul Pept       Date:  1996-11-14

3.  Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice.

Authors:  E E Ladenheim; L L Hampton; A C Whitney; W O White; J F Battey; T H Moran
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

4.  Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons.

Authors:  Anthony N van den Pol; Yang Yao; Li-Ying Fu; Kylie Foo; Hao Huang; Roberto Coppari; Bradford B Lowell; Christian Broberger
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

5.  Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist.

Authors:  E E Ladenheim; J E Taylor; D H Coy; T H Moran
Journal:  Eur J Pharmacol       Date:  1994-12-12       Impact factor: 4.432

6.  Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor.

Authors:  H Ohki-Hamazaki; Y Sakai; K Kamata; H Ogura; S Okuyama; K Watase; K Yamada; K Wada
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

7.  Fad24 causes hyperplasia in adipose tissue and improves glucose metabolism.

Authors:  Yoshikazu Johmura; Kayoko Watanabe; Keishi Kishimoto; Takashi Ueda; Shoichi Shimada; Shigehiro Osada; Makoto Nishizuka; Masayoshi Imagawa
Journal:  Biol Pharm Bull       Date:  2009-10       Impact factor: 2.233

8.  Impaired serum thyrotropin response to hypothyroidism in mice with disruption of neuromedin B receptor.

Authors:  Karen J Oliveira; Adriana Cabanelas; Marco Aurélio Lc Veiga; Gabriela Sm Paula; Tânia M Ortiga-Carvalho; Etsuko Wada; Keiji Wada; Carmen C Pazos-Moura
Journal:  Regul Pept       Date:  2007-09-14

9.  Role of neuromedin B in the in vitro thyrotropin release in response to thyrotropin-releasing hormone from anterior pituitaries of eu-, hypo-, and hyperthyroid rats.

Authors:  C C Pazos-Moura; E G Moura; V Rettori; J Polak; S M McCann
Journal:  Proc Soc Exp Biol Med       Date:  1996-04

10.  Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors.

Authors:  Xiaoyan Sheng; Yuebo Zhang; Zhenwei Gong; Cheng Huang; Ying Qin Zang
Journal:  PPAR Res       Date:  2008-12-11       Impact factor: 4.964

View more
  6 in total

Review 1.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 2.  Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Authors:  Nieves González; Paola Moreno; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2015-06-12       Impact factor: 6.902

3.  To B or not to B: Fat is the question.

Authors:  Ellen E Ladenheim
Journal:  J Physiol       Date:  2010-05-01       Impact factor: 5.182

4.  Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice.

Authors:  Eric P Zorrilla; Bruno Conti
Journal:  Brain Behav Immun       Date:  2013-12-06       Impact factor: 7.217

5.  Resveratrol treatment rescues hyperleptinemia and improves hypothalamic leptin signaling programmed by maternal high-fat diet in rats.

Authors:  J G Franco; C P Dias-Rocha; T P Fernandes; L Albuquerque Maia; P C Lisboa; E G Moura; C C Pazos-Moura; I H Trevenzoli
Journal:  Eur J Nutr       Date:  2015-03-24       Impact factor: 5.614

6.  Effects on metabolic parameters in young rats born with low birth weight after exposure to a mixture of pesticides.

Authors:  Terje Svingen; Louise Ramhøj; Karen Mandrup; Sofie Christiansen; Marta Axelstad; Anne Marie Vinggaard; Ulla Hass
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.